CMT News & Updates
See the latest news about CMT drug development and read stories from the CMT community that highlight why we must deliver treatments and cures during our lifetime.
Filter by Category
Scientific Takeaways from the Peripheral Nerve Society’s Conference
The Peripheral Nerve Society hosted its annual conference in the Netherlands this June, and our research team went to learn about the latest advances, network with field leaders and accelerate…
Read More : Scientific Takeaways from the Peripheral Nerve Society’s Conference
One Last Round: Watching Alan Jackson Ride Off Into the Sunset
On June 27, Alan Jackson plays his final concert. After nearly four decades, 35 number one hits, and a catalog that helped define what country music sounds like, he is stepping away from the stage…
Read More : One Last Round: Watching Alan Jackson Ride Off Into the Sunset
WEBINAR: Gene Therapies Demystified, Policy, Access, and the Road Ahead
https://youtu.be/AzOoaWPYpyc?si=44PoEHPxatjopWc- The first session of the CMT Research Foundation’s Gene Therapies Demystified series gave attendees the building blocks: what gene therapy is, why CMT is a compelling target, and what…
Read More : WEBINAR: Gene Therapies Demystified, Policy, Access, and the Road Ahead
Project Report: A new way to deliver drugs to nerves in CMT
One of the biggest obstacles in CMT research is not a shortage of potential therapies, but a delivery problem: nerves are extremely difficult to reach through the bloodstream. Dr. Kelly…
Read More : Project Report: A new way to deliver drugs to nerves in CMT
A Landmark Review of PMP22: The Protein at the Heart of Many CMT Cases
Dr. Charles R. Sanders featured next to stacks and stacks of papers incorporated into the review. A major new scientific review published in Chemical Reviews has assembled the most comprehensive account to date…
Read More : A Landmark Review of PMP22: The Protein at the Heart of Many CMT Cases
New FDA Draft Guidance Creates Opportunities for Gene Therapy Development
On June 2, 2026, the FDA's Center for Biologics Evaluation and Research released a draft guidance titled Leveraging Prior Knowledge in the Development of Human Gene Therapy Products Incorporating Genome Editing. …
Read More : New FDA Draft Guidance Creates Opportunities for Gene Therapy Development
Global CMT Research Convention: Highlights to Expect in 2026
The Global CMT Research Convention brings together the full spectrum of the Charcot-Marie-Tooth ecosystem in one place: leading scientists, biotech and pharma companies, investors, regulatory agencies and patients, all focused on accelerating treatments for…
Read More : Global CMT Research Convention: Highlights to Expect in 2026
Nobody Ran a Single Step at this CMTRF Fundraiser Run
Nearly 200 people gathered at Forgotten Star Brewing in Fridley, Minnesota, for one of the most unique fundraising events around: the Zero K Run, benefiting the CMT Research Foundation. The…
Read More : Nobody Ran a Single Step at this CMTRF Fundraiser Run
CMT1A Patients Dosed in Korean Phase 2a Drug Trial
ENCell, a South Korean company focused on cell and gene therapies, announced in May 2026 (as reported by Korean outlet The Bio News) that the first patient has been dosed in a…
Read More : CMT1A Patients Dosed in Korean Phase 2a Drug Trial
WEBINAR: Gene Therapies Demystified, Gene Replacement for CMT2S
The first session of the CMT Research Foundation's Gene Therapies Demystified series gave attendees the building blocks: what gene therapy is, why CMT is a compelling target, and what the…
Read More : WEBINAR: Gene Therapies Demystified, Gene Replacement for CMT2S
